Neurofeedback Therapy for Children Diagnosed With Autism

Completed · Not applicable · Has a placebo group

Conditions studied: Autism Spectrum Disorder

In brief

This project aims: * to further explore the effectiveness of a novel sonified Neurofeedback management therapy for children diagnosed with Autism Spectrum Disorder (ASD) * to determine if balance control is different before and after therapy

Key facts

Study ID

NCT02773303

Run by

Carrick Institute for Graduate Studies

People needed

83

Starts

2016-05-01

Expected to finish

2017-12-13

Last updated by the study team

2018-07-24

Who can join

Age: 2 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• a clear diagnosis of ASD and a high starting delta wave level, as confirmed by the initial qEEG.
• Furthermore, since the therapy is administered via a device requiring to be connected to a computer, tablet or phone with WiFi capabilities to work, the following are additional requirement:
• iPhone 4s or later or all iPads except first generation iPAD running OS v7 or later, or
• computer running Windows 7 or later
• Tablet running Android 4.1 or later
• Internet connection

You may not qualify if…

• a history of hearing impairment and co-morbidities such as Rett-Syndrome and if they get low delta wave recordings in frontal lobe with qEEG (part of the baseline testing battery)

Where it is running

• Plasticity Brain Centers — Orlando, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.